Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | $53.01 | $60.69 | -12.65% | 28.65x | 13.16x | 9.69x | 5.57x | 0.36x | $105.42M | 3.82% | $495.80M | 9.52 | $2.68B | 24.95 | ||
| LQDA | LIQUIDIA CORP | $56.93 | $17.58 | 223.76% | 237.21x | 21.05x | 17.39x | 46.63x | 1.20x | $41.15M | 0.82% | $108.58M | 1.23 | $5.02B | 93.73 | ||
| ADMA | ADMA BIOLOGICS INC | $8.27 | $11.76 | -29.65% | 11.99x | 8.33x | 3.83x | 4.91x | 0.35x | $107.90M | 5.53% | $390.33M | 1.65 | $1.98B | 8.92 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $286.98 | $98.54 | 191.23% | 65.82x | 40.47x | 8.90x | 35.63x | 1.31x | $641.34M | 1.68% | $1.08B | 8.09 | $39.57B | 42.81 | ||
| CORT | CORCEPT THERAPEUTICS INC | $56.37 | $16.18 | 248.29% | 122.54x | 103.89x | 7.65x | 9.49x | 1.41x | $119.79M | 2.03% | $637.99M | 6.11 | $5.95B | -866.93 | ||
| OMER | OMEROS CORP | $12.25 | $17.93 | -31.69% | 9.42x | -20.13x | 88.77x | -14.00x | 0.38x | -$94.78M | -10.76% | -$63.33M | -0.88 | $1.20B | 13.22 | ||
| KRYS | KRYSTAL BIOTECH INC | $306.29 | $102.49 | 198.85% | 39.52x | 38.96x | 21.50x | 7.07x | 1.72x | $237.38M | 2.65% | $1.28B | 43.59 | $8.54B | 39.90 | ||
| ASND | ASCENDIS PHARMA A | $240.50 | $103.71 | 131.89% | 25.49x | 56.38x | 14.67x | 26.02x | 1.55x | $52.94M | 0.35% | $574.09M | 9.24 | $15.32B | 164.27 | ||
| HALO | HALOZYME THERAPEUTICS INC | $67.12 | $71.67 | -6.35% | 22.68x | 8.14x | 5.26x | 36.25x | 0.41x | $667.65M | 8.42% | $219.64M | 1.86 | $9.79B | 15.70 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.24 | $2.86 | 118.06% | 89.14x | 52.22x | 3.38x | 82.80x | 0.86x | $47.52M | 4.47% | $13.01M | 0.08 | $1.22B | 22.91 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.01 | $16.36 | -32.70% | 5.37x | 22.21x | 5.26x | 3.16x | 0.70x | $56.42M | 8.77% | $205.80M | 3.52 | $556.41M | 3.85 | ||
| VCEL | VERICEL CORP | $33.03 | $8.77 | 276.72% | 76.81x | 74.44x | 5.74x | 4.74x | 1.75x | $47.49M | 2.83% | $356.23M | 7.02 | $1.67B | 41.37 | ||
| RPRX | ROYALTY PHARMA PLC | $52.85 | $42.19 | 25.26% | 27.67x | 9.99x | 9.46x | 3.06x | 0.57x | $2.34B | 10.14% | $9.94B | 22.75 | $38.80B | 33.35 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.65 | $3.03 | 20.55% | 15.21x | 13.37x | 2.24x | 3.53x | 0.72x | $4.11M | 1.40% | $82.33M | 1.03 | $226.73M | 10.67 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $51.81 | $41.75 | 24.10% | 37.01x | 11.47x | 3.08x | 1.61x | 0.52x | $767.06M | 7.69% | $6.21B | 32.27 | $8.37B | 17.35 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $56.51 | $16.19 | 249.09% | 57.66x | 51.23x | 5.73x | 7.18x | 1.77x | $164.23M | 3.80% | $605.69M | 7.92 | $4.17B | 37.38 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $228.77 | $49.21 | 364.89% | 486.74x | 9.40x | 3.19x | 3.17x | 1.68x | $1.30B | 9.16% | $4.53B | 73.22 | $17.91B | 26.53 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.49 | $6.98 | -21.39% | 4.39x | -6.66x | 21.36x | 2.16x | 6.78x | -$85.24M | -27.41% | $144.94M | 2.56 | $274.70M | 3.74 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $30.09 | $35.66 | -15.62% | 11.89x | 8.43x | 1.94x | 1.91x | 0.47x | $341.79M | 19.64% | $910.35M | 15.75 | $1.31B | 5.53 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.79 | $5.84 | -52.23% | 10.33x | 4.08x | 2.61x | 3.05x | 0.22x | $7.24M | 4.52% | $52.93M | 0.92 | $107.89M | 6.96 | ||
| TECH | BIO-TECHNE CORP | $43.30 | $16.62 | 160.54% | 60.99x | 21.41x | 5.59x | 3.25x | 1.16x | $269.60M | 3.98% | $2.09B | 13.34 | $6.86B | 26.80 | ||
| EXEL | EXELIXIS INC | $50.13 | $31.38 | 59.75% | 16.07x | 15.98x | 5.45x | 6.51x | 1.17x | $917.69M | 7.09% | $1.94B | 7.49 | $12.54B | 11.88 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $213.21 | $82.30 | 159.06% | 26.99x | 23.12x | 15.44x | 4.28x | 1.83x | $122.22M | 2.88% | $997.32M | 50.16 | $4.61B | 20.44 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.18 | $14.54 | 114.50% | 17.23x | 15.10x | 6.39x | 3.77x | 2.21x | $208.13M | 5.46% | $1.01B | 8.28 | $3.06B | 9.14 | ||
| UTHR | UNITED THERAPEUTICS CORP | $568.58 | $265.32 | 114.30% | 19.42x | 19.28x | 7.80x | 4.09x | 1.80x | $1.02B | 4.11% | $5.90B | 135.66 | $22.85B | 13.34 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.55 | $6.83 | 156.79% | 29.25x | 5.51x | 0.84x | 1.23x | 1.66x | $109.24M | 5.93% | $1.51B | 14.34 | $2.43B | 29.31 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.98 | $1.77 | 11.65% | 10.42x | 9.12x | 2.07x | 2.37x | 0.90x | $13.00M | 8.23% | $67.23M | 0.84 | $126.30M | 5.66 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $436.95 | $176.98 | 146.89% | 25.69x | 22.44x | 9.09x | 5.73x | 1.74x | $3.71B | 3.34% | $19.36B | 76.20 | $107.39B | 19.91 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $6.92 | $4.37 | 58.34% | 13.84x | 16.96x | 1.55x | 2.74x | 1.40x | $53.60M | 15.23% | $128.42M | 2.53 | $329.89M | 7.33 | ||
| MDXG | MIMEDX GROUP INC | $3.56 | $1.79 | 98.34% | 16.95x | -261.76x | 1.36x | 2.18x | 1.82x | $69.36M | 13.12% | $242.94M | 1.64 | $388.07M | 7.12 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $698.25 | $437.38 | 59.64% | 16.41x | 14.82x | 4.87x | 2.33x | 1.14x | $4.11B | 5.66% | $31.42B | 302.15 | $72.95B | 12.70 | ||
| VCYT | VERACYTE INC | $38.48 | $9.04 | 325.52% | 34.67x | 42.07x | 5.65x | 2.28x | 4.27x | $155.34M | 5.08% | $1.34B | 16.90 | $2.84B | 24.73 | ||
| INCY | INCYTE CORP | $95.31 | $67.81 | 40.56% | 13.07x | 12.16x | 3.54x | 3.39x | 1.14x | $1.45B | 7.64% | $5.62B | 28.21 | $15.61B | 8.34 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.